Sagimet Biosciences logo

Sagimet Biosciences

SGMT | NASDAQ
Chart Builder DCF Calculator
$10.13
-$0.09 (-0.88%)
At close: Nov 16, 2026, 4:00 PM ET
$10.33
+$0.20 (+1.97%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.88%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
28.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #833/1021 (Top 82%)

Key Statistics

Market Data

Market Cap $712.56M
1D Range
10.02 10.44
52W Range
4.55 11.41

Valuation (TTM)

PE -8.51
PB 2.94
EV/EBITDA -8.55

Valuation (NTM)

Forward PE N/A
Forward PEG 0.31
Price Target $26.00
Loading financial charts...

Profile

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctio...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Jul 14, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$26.00
Upside
+156.66%
Buy (6)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.